Valérie Martelange

Title: Valérie Martelange: Innovator in Tumor Associated Nucleic Acids

Introduction

Valérie Martelange is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of cancer research, particularly in the area of tumor associated nucleic acids. His work has implications for diagnosing and treating various conditions related to cancer.

Latest Patents

Valérie Martelange holds a patent titled "Tumor associated nucleic acids and uses therefor." This invention describes SAGE (sdph3.10) and sdp3.5 tumor associated nucleic acids, including fragments and biologically functional variants thereof. The patent also includes polypeptides and fragments encoded by such nucleic acid molecules, along with antibodies related to them. Furthermore, methods and products are provided for diagnosing and treating conditions characterized by the expression of a sdph3.10 and/or sdp3.5 gene product.

Career Highlights

Valérie Martelange is affiliated with the Ludwig Institute for Cancer Research Limited, where he continues to advance his research in cancer-related innovations. His work is pivotal in understanding the molecular mechanisms of tumors and developing targeted therapies.

Collaborations

He has collaborated with esteemed colleagues such as Charles De Smet and Thierry R Boon-Falleur, contributing to a rich environment of research and innovation in cancer studies.

Conclusion

Valérie Martelange's contributions to the field of cancer research through his patent on tumor associated nucleic acids highlight his role as an influential inventor. His work continues to pave the way for advancements in cancer diagnosis and treatment.